Sugi Predict

Sugi Predict / Compounds / SCHEMBL23329109

SCHEMBL23329109

SCHEMBL23329109

COCCO[C@@H]1CC[C@@H](N(Cc2ccccc2)Cc2ccccc2)C1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ YTHDC1 Q96MU7 1/20 0.39
▸ SLC6A2 P23975 2/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ KMT2A Q03164 2/20 0.37
▸ DRD2 P14416 1/20 0.36
▸ CD38 P28907 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ACKR3 P25106 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23304768 1.00 YTHDC1 (0.39) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL5009994 0.93 YTHDC1 (0.43) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL5006779 0.93 YTHDC1 (0.43) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL23329876 0.93 YTHDC1 (0.43) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
Hydrochloric Acid SCHEMBL21222657 0.91 YTHDC1 (0.42) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
Hydrochloric Acid SCHEMBL21222660 0.91 YTHDC1 (0.42) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL23329102 0.91 SLC6A2 (0.38) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL23329406 0.91 SLC6A2 (0.38) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL23329412 0.91 SLC6A2 (0.38) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL23329107 0.84 KMT2A (0.41) YTHDC1SLC6A2SLC6A4SLC6A3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370512-A1 CD38 MODULATORS AND METHODS OF USE THEREOF Cytokinetics, Inc. (US) 2024-05-22 — — EP disclosed
US-20230116972-A1 CD38 MODULATORS AND METHODS OF USE THEREOF CYTOKINETICS, INC. 2023-04-20 — — US disclosed
US-20230116972-A1 CD38 MODULATORS AND METHODS OF USE THEREOF CYTOKINETICS, INC. 2023-04-20 — — US disclosed
US-20230025807-A1 CD38 INHIBITORS Astellas Engineered Small Molecules US, Incorporated 2023-01-26 — — US disclosed
WO-2023288195-A1 CD38 MODULATORS AND METHODS OF USE THEREOF CYTOKINETICS, INC. (US) 2023-01-19 — — WO disclosed
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025807-A1 CD38 INHIBITORS CD38, GLS, IDH2 YTHDC1 2791/4885SLC6A2 513/4885SLC6A4 1662/4885
US-20230116972-A1 CD38 MODULATORS AND METHODS OF USE THEREOF CD38, CXCR4, FCGRT YTHDC1 3620/4885SLC6A2 1106/4885SLC6A4 1596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.